leisure time -WSS

leisure time

author：knowledge 2025-09-27 10:46:17 - browse：42

Japanese drugmaker Eisai said Tuesday that Ivan Cheung, chairman of its U.S. operations and global head of its Alzheimer’s disease unit, will retire at the end of the month. The surprise announcement comes just days after Eisai won final approval in the U.S. for its Alzheimer’s drug Leqembi.

Cheung will be replaced in his capacity as head of the Alzheimer’s unit by his brother-in-law Keisuke Naito, 34, who is currently chief ecosystem officer and chief strategy officer. He is also the son of Eisai CEO Haruo Naito.

Tatsuyuki Yasuno, current chief financial officer, will replace Cheung as head of Eisai’s U.S. unit.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Roche subsidiary Foundation Medicine opens new headquarters

Wikipedia

WSS

Why the world’s most expensive drug might be worth the price

FDA's naming rule on biosimilars has undermined competition

Bryan Kohberger seeks indictment dismissal in Idaho college killings case

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

Covid vaccine financial winners and losers, from Pfizer to Novavax

focus

leisure time

focus

DIEP, the 'gold standard' of breast reconstruction, is under threat

Study says nonprofit hospitals fall short in charity care spending

The cancer drug shortage isn’t new — and neither are the solutions

‘We were in the air.’ Mississippi family recounts surviving tornado that tore mobile home apart

In Memoriam: Notable people who died in 2023

Trader Joe's recalls 10K cases of broccoli cheddar soup over potential foreign material

Novavax promises a turnaround & Lilly roils the obesity market

States should stop sabotaging methadone treatment reform

Malaria cases in Florida and Texas: Here’s what you need to know

Decaf coffee targeted by food safety group under obscure FDA rule

focus

Study says nonprofit hospitals fall short in charity care spending

Merck drug for rare lung condition set for approval in U.S.

'The boss' wants server deleted: New allegations emerge in Trump indictment

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

Moscow blames Kyiv for missile attacks in southern Russia as Kremlin forces pound Ukrainian village

explore

Wikipedia

leisure time

hotspot